|Day Low/High||145.26 / 147.14|
|52 Wk Low/High||109.16 / 157.00|
Jim Cramer wonders whether someone at Johnson & Johnson is now willing to pay more for Actelion, or if there was more give from the other side.
This is what you need to know before the opening bell on Thursday.
The Fed seems to have aligned itself with the new emerging themes of financials and small-caps.
Jim Cramer comments on Johnson & Johnson's move to abandon merger talks with Actelion.
The markets moved lower from the "get go," though about the time Sixty Minutes was on last evening the S&P 500 futures were up 10 handles. (Futures closed down 2.5 handles) Perhaps this is the start of a well due correction. Apropos, here is the q...
It's simply a little consolidation after a huge run. But could it develop?
There's a striking lack of volatility, and that's a flashing red warning signal.
But who are these buyers? Where are the sellers?
Jim Cramer is watching Johnson & Johnson, which may buy a Swiss drugmaker. Cramer says it's important to see how the deal is structured.
This stock needs more aggressive buying before it is an outright long.
It may be time to embrace the contrary. First issue (!!): The Palm Beach Chronicles. My weekly (brief) technical review of the markets -- cooling off ahead? BTIG's Stockton is bullish and so, as I have expressed, are most others! Campbell ...
Technical support and statistical evidence suggest the stock will rebound.
"If you work for a living, why the hell do you kill yourself working?" -- Tuco the Ugly "The Good, the Bad and the Ugly" I did only a small amount of trading today (and added to short exposure), and there will be no "Takeaways" today (it's family ti...
Jim Cramer takes a moment to honor American veterans, and the companies who are working to support them.
But don't buy blindly. There are too many companies that can be retaliated against.
"Dougie, take what Mr. Market gives you." -- Grandma Koufax And I did, Grandma Koufax. A consecutive nine-day market drop was snapped as we regained most that was lost in that period. Today was a great day. (Boy, would I like to annualize the pe...
After the election passes we are going to talk about companies again -- and these have done well.
Stocks in the health care sector seem to have no underpinnings whatsoever.
The debt-laden drugmaker needs to shore up cash, but a Salix sale might be too rash a move.
We have to ask: where is the cash flow to pay off the debt, if any important prices are rolled back?
Since mid- July there have been numerous negative divergences. One clear example is the chart below of new highs. During this three-and-a-half month period the S&P 500 has traded in a range above 2125 (the post-Brexit breakout). Downside attempts li...
For starters, trouble for banks, drugs, energy and M&A.
Jim Cramer reflects on a dramatic day of selling on Wall Street that forever changed the industry.
"I've never seen so many men wasted so badly." -- Blondie in The Good, the Bad and the Ugly." And now it's time to run down "The Good, the Bad and the Ugly" ... The Good The market was up from the get-go. (T)FANG is the world's fair. High beta was...
Back at morning highs and facing mild resistance at S&P 500 Index 2145/2149. WTI above $50 seems to put a bid under stocks, below $50 not so much. Stocks here and across the pond helped by rumors that sovereign funds may buy more equities. Volume a ...
U.S. stocks held higher as a series of positive earnings reports filtered in on Tuesday. Netflix boosted the Nasdaq, while Goldman Sachs pushed the Dow Jones Industrial Average higher.
On Tuesday, October 18, Goldman Sachs (GS) and Yahoo! (YHOO) release quarterly results.